Literature DB >> 32003480

Expanded carrier screening for preconception reproductive risk assessment: Prevalence of carrier status in a Mexican population.

Carlos Hernandez-Nieto1,2, Tamar Alkon-Meadows1,2, Joseph Lee1, Teresa Cacchione1, Esther Iyune-Cojab2, Maria Garza-Galvan2, Martha Luna-Rojas1,2, Alan B Copperman1,3,4, Benjamin Sandler1,3,2.   

Abstract

OBJECTIVE: Genetic carrier screening has the potential to identify couples at risk of having a child affected with an autosomal recessive or X-linked disorder. However, the current prevalence of carrier status for these conditions in developing countries is not well defined. This study assesses the prevalence of carrier status of selected genetic conditions utilizing an expanded, pan-ethnic genetic carrier screening panel (ECS) in a large population of Mexican patients.
METHODS: Retrospective chart review of all patients tested with a single ECS panel at an international infertility center from 2012 to 2018 were included, and the prevalence of positive carrier status in a Mexican population was evaluated.
RESULTS: Eight hundred five individuals were analyzed with ECS testing for 283 genetic conditions. Three hundred fifty-two carriers (43.7%) were identified with 503 pathogenic variants in 145 different genes. Seventeen of the 391 participating couples (4.34%) were identified as being at-risk couples. The most prevalent alleles found were associated with alpha thalassemia, cystic fibrosis, GJB2 nonsyndromic hearing loss, biotinidase deficiency, and familial Mediterranean fever.
CONCLUSION: Based on the prevalence and severity of Mendelian disorders, we recommend that couples who wish to conceive regardless of their ethnicity background explore carrier screening and genetic counseling prior to reproductive medical treatment.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32003480     DOI: 10.1002/pd.5656

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  Assessing clinical utility of preconception expanded carrier screening regarding residual risk for neurodevelopmental disorders.

Authors:  Paranchai Boonsawat; Anselm H C Horn; Katharina Steindl; Alessandra Baumer; Pascal Joset; Dennis Kraemer; Angela Bahr; Ivan Ivanovski; Elena M Cabello; Michael Papik; Markus Zweier; Beatrice Oneda; Pietro Sirleto; Tilo Burkhardt; Heinrich Sticht; Anita Rauch
Journal:  NPJ Genom Med       Date:  2022-07-29       Impact factor: 6.083

2.  Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China.

Authors:  Keya Tong; Wenbin He; Yao He; Xiurong Li; Liang Hu; Hao Hu; Guangxiu Lu; Ge Lin; Chang Dong; Victor Wei Zhang; Juan Du; Dongyun Liu
Journal:  Front Genet       Date:  2022-08-22       Impact factor: 4.772

3.  Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG.

Authors:  C A González-Domínguez; C E Villarroel; M Rodríguez-Morales; S Manrique-Hernández; A González-Jaimes; F Olvera-Rodriguez; K Beutelspacher; C Molina-Garay; K Carrillo-Sánchez; L L Flores-Lagunes; M Jiménez-Olivares; A Muñoz-Rivas; M E Cruz-Muñoz; H M Mora-Montes; R Salinas-Marín; C Alaez-Verson; I Martínez-Duncker
Journal:  Mol Genet Metab Rep       Date:  2021-07-02

4.  Common disease-associated gene variants in a Saudi Arabian population.

Authors:  Mariam Aleissa; Taghrid Aloraini; Lamia Fahad Alsubaie; Madawi Hassoun; Ghada Abdulrahman; Abdulrahman Swaid; Wafa Al Eyaid; Fuad Al Mutairi; Faroug Ababneh; Majid Alfadhel; Ahmed Alfares
Journal:  Ann Saudi Med       Date:  2022-02-03       Impact factor: 1.526

Review 5.  Current Updates on Expanded Carrier Screening: New Insights in the Omics Era.

Authors:  Iolanda Veneruso; Chiara Di Resta; Rossella Tomaiuolo; Valeria D'Argenio
Journal:  Medicina (Kaunas)       Date:  2022-03-21       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.